Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 4,281 $ 3,930
Premium and related receivables 3,955 3,098
Short-term investments 595 505
Other current assets 829 832
Total current assets 9,660 8,365
Long-term investments 4,927 4,545
Restricted deposits 138 138
Property, software and equipment, net 1,003 797
Goodwill 4,712 4,712
Intangible assets, net 1,428 1,545
Other long-term assets 132 95
Total assets 22,000 20,197
Current liabilities:    
Medical claims liability 4,333 3,929
Accounts payable and accrued expenses 4,804 4,377
Unearned revenue 568 313
Current portion of long-term debt 4 4
Total current liabilities 9,709 8,623
Long-term debt 4,717 4,651
Other long-term liabilities 901 869
Total liabilities 15,327 14,143
Commitments and contingencies
Redeemable noncontrolling interests 20 145
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2017 and December 31, 2016 0 0
Common stock, $0.001 par value; authorized 400,000 shares; 179,033 issued and 172,566 outstanding at September 30, 2017, and 178,134 issued and 171,919 outstanding at December 31, 2016 0 0
Additional paid-in capital 4,310 4,190
Accumulated other comprehensive earnings (loss) 9 (36)
Retained earnings 2,518 1,920
Treasury stock, at cost (6,467 and 6,215 shares, respectively) (197) (179)
Total Centene stockholders’ equity 6,640 5,895
Noncontrolling interest 13 14
Total stockholders’ equity 6,653 5,909
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 22,000 $ 20,197